214 results
Page 7 of 11
8-K
EX-99.1
dg9 rvp6569ayxi
14 Sep 21
Regulation FD Disclosure
12:00am
8-K
EX-99.1
liadvwvuvjt
9 Aug 21
Akerna Announces Financial Results for the Second Quarter 2021
5:18pm
424B5
pfi1 jkc67
23 Jul 21
Prospectus supplement for primary offering
5:07pm
424B3
vl78c tezw4jldgnjcr
23 Jul 21
Prospectus supplement
4:49pm
424B3
um7vgki
4 Jun 21
Prospectus supplement
5:22pm
POS AM
xexvx q2z
21 May 21
Prospectus update (post-effective amendment)
8:26pm
8-K
EX-99.1
ybj13y3lfjdx2lcqa
11 May 21
Akerna Announces Financial Results for the First Quarter 2021
10:35am
DEFA14A
r087jn nc707j1x
27 Apr 21
Additional proxy soliciting materials
5:21pm
10-KT
jiz33p
31 Mar 21
Annual report (with FYE transition)
3:05pm
10-KT
EX-3.2
ta8rd6wgmgf3 3gdt
31 Mar 21
Annual report (with FYE transition)
3:05pm
8-K
EX-99.1
97z7 jq395
22 Mar 21
Results of Operations and Financial Condition
4:55pm
8-K
EX-99.1
35a6jt9y snxpkpek02
11 Mar 21
Akerna to Acquire Viridian Sciences
8:38am
424B3
axk4sdx9
10 Feb 21
Prospectus supplement
5:11pm
POS AM
0bx h4n56uw4r
7 Jan 21
Prospectus update (post-effective amendment)
9:56pm